Laddar...
Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancer
Vandetanib (ZD6474) is an oral small molecule inhibitor of multiple intracellular receptor kinases, including the vascular endothelial growth factor receptor (VEGFR) -2 and epidermal growth factor receptor (EGFR). Both VEGFR and EGFR pathways have emerged as instrumental in the growth and metastasis...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2010
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2943196/ https://ncbi.nlm.nih.gov/pubmed/20859451 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|